ArticleInternational journal of molecular sciences2022

Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer.

Ho Tsoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.